{
    "2019-06-14": [
        [
            {
                "time": "",
                "original_text": "贝达药业：多个新药进入III期临床研究",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "新药",
                        "III期临床研究"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“科创板过会第一股”微芯生物定价猜想",
                "features": {
                    "keywords": [
                        "科创板",
                        "过会第一股",
                        "微芯生物",
                        "定价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}